EXPRESSION  OF  MAGE-3  GENE  IN  NON-SMALL  CELL  LUNG  CANCER
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:非小细胞肺癌MAGE-3基因的表达
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Tao LI
			        		
			        		;
		        		
		        		
		        		
			        		Yaochang SUN
			        		
			        		;
		        		
		        		
		        		
			        		Zhife XU
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		lung neoplasms;
			        		
			        		
			        		
				        		MAGE-3;
			        		
			        		
			        		
				        		gene immunotherapy;
			        		
			        		
			        		
				        		RT-PCR
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Medical Journal of Chinese People's Liberation Army
	            		
	            		 1982;0(03):-
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	To explore the possibility of using tumor antigen encoded by MAGE-3 gene as the target for immunotherapy for non-small cell lung cancer (NSCLC) patients, the expression of MAGE-3 mRNA in 3 human lung cancer cell lines and 56 NSCLC samples together with the adjacent normal lung samples was determined by RT-PCR. The results showed that all 3 human lung cancer cell lines expressed MAGE-3 mRNA; of the 56 NSCLC samples, 30 expressed MAGE-3 mRNA. The expression rate in squamous cell carcinoma was significantly higher than in adenocarcinoma, whereas none of the adjacent normal lung samples expressed MAGE-3 mRNA. This study suggests that MAGE-3 mRNA is expressed in a high percentage in NSCLC specimens, and its encoding tumor antigen may be the target for immunotherapy for NSCLC patients.